Application 065197
- Type
- ANDA
- Sponsor
- WOCKHARDT
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | CEFOTAXIME | CEFOTAXIME SODIUM | INJECTABLE;INJECTION | EQ 1GM BASE/VIAL | No | No |
| 002 | CEFOTAXIME SODIUM | CEFOTAXIME SODIUM | INJECTABLE;INJECTION | EQ 500MG BASE/VIAL | No | No |
| 003 | CEFOTAXIME SODIUM | CEFOTAXIME SODIUM | INJECTABLE;INJECTION | EQ 2GM BASE/VIAL | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A065197-001 | CEFOTAXIME | CEFOTAXIME SODIUM | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | 2006-08-29 | ||
| A065197-002 | CEFOTAXIME SODIUM | CEFOTAXIME SODIUM | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | 2008-06-20 | ||
| A065197-003 | CEFOTAXIME SODIUM | CEFOTAXIME SODIUM | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | 2008-06-20 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2020-11-12 02:37 UTC | 2020-11 | A065197-003 | CEFOTAXIME SODIUM | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | 2008-06-20 | c0c555d07b60… | ||
| 2019-12-14 00:12 UTC | 2019-12 | A065197-001 | CEFOTAXIME | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | 2006-08-29 | 3f01610625f2… | ||
| 2019-12-14 00:12 UTC | 2019-12 | A065197-002 | CEFOTAXIME SODIUM | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | 2008-06-20 | 3f01610625f2… | ||
| 2019-12-14 00:12 UTC | 2019-12 | A065197-003 | CEFOTAXIME SODIUM | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | 2008-06-20 | 3f01610625f2… | ||
| 2019-09-15 20:21 UTC | 2019-09 | A065197-001 | CEFOTAXIME | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2006-08-29 | b00525d2431f… | |
| 2019-09-15 20:21 UTC | 2019-09 | A065197-002 | CEFOTAXIME SODIUM | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | AP | 2008-06-20 | b00525d2431f… | |
| 2019-09-15 20:21 UTC | 2019-09 | A065197-003 | CEFOTAXIME SODIUM | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2008-06-20 | b00525d2431f… | |
| 2019-07-19 19:46 UTC | 2019-07 | A065197-001 | CEFOTAXIME | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2006-08-29 | ea99ee380514… | |
| 2019-07-19 19:46 UTC | 2019-07 | A065197-002 | CEFOTAXIME SODIUM | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | AP | 2008-06-20 | ea99ee380514… | |
| 2019-07-19 19:46 UTC | 2019-07 | A065197-003 | CEFOTAXIME SODIUM | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2008-06-20 | ea99ee380514… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A065197-001 | CEFOTAXIME | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | 2006-08-29 | 6a51e52b5d6a… | ||
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A065197-002 | CEFOTAXIME SODIUM | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | 2008-06-20 | 6a51e52b5d6a… | ||
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A065197-003 | CEFOTAXIME SODIUM | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | 2008-06-20 | 6a51e52b5d6a… | ||
| 2024-02-18 07:12 UTC | 2024-02 | A065197-001 | CEFOTAXIME | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | 2006-08-29 | 1c564ffb4f44… | ||
| 2024-02-18 07:12 UTC | 2024-02 | A065197-002 | CEFOTAXIME SODIUM | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | 2008-06-20 | 1c564ffb4f44… | ||
| 2024-02-18 07:12 UTC | 2024-02 | A065197-003 | CEFOTAXIME SODIUM | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | 2008-06-20 | 1c564ffb4f44… | ||
| 2023-12-20 04:57 UTC | 2023-12 | A065197-001 | CEFOTAXIME | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | 2006-08-29 | ea1830bbd6c7… | ||
| 2023-12-20 04:57 UTC | 2023-12 | A065197-002 | CEFOTAXIME SODIUM | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | 2008-06-20 | ea1830bbd6c7… | ||
| 2023-12-20 04:57 UTC | 2023-12 | A065197-003 | CEFOTAXIME SODIUM | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | 2008-06-20 | ea1830bbd6c7… | ||
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A065197-001 | CEFOTAXIME | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | 2006-08-29 | a72a2bbeb626… | ||
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A065197-002 | CEFOTAXIME SODIUM | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | 2008-06-20 | a72a2bbeb626… | ||
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A065197-003 | CEFOTAXIME SODIUM | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | 2008-06-20 | a72a2bbeb626… | ||
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A065197-001 | CEFOTAXIME | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | 2006-08-29 | 9b2671bbb829… | ||
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A065197-002 | CEFOTAXIME SODIUM | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | 2008-06-20 | 9b2671bbb829… | ||
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A065197-003 | CEFOTAXIME SODIUM | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | 2008-06-20 | 9b2671bbb829… | ||
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A065197-001 | CEFOTAXIME | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | 2006-08-29 | a67488948f0b… | ||
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A065197-002 | CEFOTAXIME SODIUM | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | 2008-06-20 | a67488948f0b… | ||
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A065197-003 | CEFOTAXIME SODIUM | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | 2008-06-20 | a67488948f0b… | ||
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A065197-001 | CEFOTAXIME | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | 2006-08-29 | 3f0d92c62455… | ||
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A065197-002 | CEFOTAXIME SODIUM | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | 2008-06-20 | 3f0d92c62455… | ||
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A065197-003 | CEFOTAXIME SODIUM | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | 2008-06-20 | 3f0d92c62455… | ||
| 2023-05-13 08:27 UTC | 2023-05 | A065197-001 | CEFOTAXIME | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | 2006-08-29 | 053a50430f4f… | ||
| 2023-05-13 08:27 UTC | 2023-05 | A065197-002 | CEFOTAXIME SODIUM | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | 2008-06-20 | 053a50430f4f… | ||
| 2023-05-13 08:27 UTC | 2023-05 | A065197-003 | CEFOTAXIME SODIUM | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | 2008-06-20 | 053a50430f4f… | ||
| 2023-01-26 05:58 UTC | 2023-01 | A065197-001 | CEFOTAXIME | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | 2006-08-29 | 3bdfa0b2c4d7… | ||
| 2023-01-26 05:58 UTC | 2023-01 | A065197-002 | CEFOTAXIME SODIUM | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | 2008-06-20 | 3bdfa0b2c4d7… | ||
| 2023-01-26 05:58 UTC | 2023-01 | A065197-003 | CEFOTAXIME SODIUM | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | 2008-06-20 | 3bdfa0b2c4d7… | ||
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A065197-001 | CEFOTAXIME | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | 2006-08-29 | 3a93d1ddd44b… | ||
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A065197-002 | CEFOTAXIME SODIUM | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | 2008-06-20 | 3a93d1ddd44b… | ||
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A065197-003 | CEFOTAXIME SODIUM | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | 2008-06-20 | 3a93d1ddd44b… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2019-12-13 00:20 UTC | 2019-12 | A065197-001 | AP | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | A065197-002 | AP | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | A065197-003 | AP | 1 | 74a2ff9319b5… |
| 2019-09-15 20:21 UTC | 2019-09 | A065197-001 | AP | 1 | b00525d2431f… |
| 2019-09-15 20:21 UTC | 2019-09 | A065197-002 | AP | 1 | b00525d2431f… |
| 2019-09-15 20:21 UTC | 2019-09 | A065197-003 | AP | 1 | b00525d2431f… |
| 2019-07-19 19:46 UTC | 2019-07 | A065197-001 | AP | 1 | ea99ee380514… |
| 2019-07-19 19:46 UTC | 2019-07 | A065197-002 | AP | 1 | ea99ee380514… |
| 2019-07-19 19:46 UTC | 2019-07 | A065197-003 | AP | 1 | ea99ee380514… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Cefotaxime | CEFOTAXIME INJECTION | SteriMax Inc. | 8efe3bd0-c43a-2bd6-e053-2a95a90a92fa | 2026-06-15 | Cefotaxime | |
| Cefotaxime | CEFOTAXIME | Hikma Pharmaceuticals USA Inc. | ed23b6bc-32c7-4c50-a53d-313ae78e5623 | 2024-04-11 | Warnings, Adverse reactions | Cefotaxime |
| Cefotaxime | CEFOTAXIME | Hikma Pharmaceuticals USA Inc. | ef1a6dc6-bc3d-4f09-8f92-7ff328f56561 | 2024-04-11 | Warnings, Adverse reactions | Cefotaxime |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 55648-947 | CEFOTAXIME | CEFOTAXIME | WOCKHARDT LIMITED | ANDA | Current |
| 55648-948 | CEFOTAXIME | CEFOTAXIME | WOCKHARDT LIMITED | ANDA | Current |
| 55648-986 | CEFOTAXIME | CEFOTAXIME | WOCKHARDT LIMITED | ANDA | Current |
| 64679-947 | Cefotaxime | Cefotaxime | Wockhardt USA LLC. | ANDA | Current |
| 64679-947 | Cefotaxime | Cefotaxime | Wockhardt USA LLC. | ANDA | Current |
| 64679-948 | Cefotaxime | Cefotaxime | Wockhardt USA LLC. | ANDA | Current |
| 64679-948 | Cefotaxime | Cefotaxime | Wockhardt USA LLC. | ANDA | Current |
| 64679-986 | Cefotaxime | Cefotaxime | Wockhardt USA LLC. | ANDA | Current |
| 64679-986 | Cefotaxime | Cefotaxime | Wockhardt USA LLC. | ANDA | Current |